Preventing Suicide among Psychiatric Inpatients with Psychotic Depression

Autor: Kristin J Fredriksen, Helle K. Schoeyen, Margrethe Aase Schaufel, Larry Davidson, Fredrik A. Walby, Jan Olav Johannessen

Publikováno v: Psychiatric Quarterly. 91:223-236

To investigate which factors individuals with a psychotic depression experience as preventive of suicide while beeing hospitalized. Semi-structured qualitative interviews with nine inpatients, all hospitalized for a unipolar or bipolar depressive epi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e77fbdf4be295399e10caa1174ab52
https://doi.org/10.1007/s11126-019-09677-6

Clinical predictors of non-response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study

Autor: Paul D. Shilling, John I. Nurnberger, Michael McCarthy, Martin Alda, Megan Ritchey, Wade H. Berrettini, Vigdis Elin Giever Syrstad, Cynthia V. Calkin, Peter P. Zandi, Gloria Harrington, Fernando S. Goes, William Coryell, Elliot S. Gershon, Yokesh Balaraman, Toyomi Goto, Elizabeth Karberg, Abesh Kumar Bhattacharjee, Joseph R. Calabrese, Bruce Tarwater, Caroline M. Nievergelt, Helle K. Schoeyen, Kelly A. Ryan, John R. Kelsoe, Joanna M. Biernacka, Julie Garnham, Masoud Kamali, Kara Glazer, Falk W. Lohoff, Francis M. Mondimore, Gunnar Morken, Yian Lin, Ney Alliey-Rodriguez, Mark A. Frye, Nicole Frazier, Petter Jakobsen, Marth Shaw, Ole A. Andreassen, Melvin G. McInnis, Adam X. Maihofer, Martha Schinagle, Emma K. Stapp, Susan G. Leckband, Keming Gao, Amit Anand, Carrie Fisher, Marisa Kelly, Claire Slaney, Andrea Stautland, Carla Conroy, Ketil J. Oedegaard, Anna DeModena, Nicole D'Arcangelo, Holli Bertram

Publikováno v: Bipolar Disorders

Background Lithium is regarded as a first-line treatment for bipolar disorder (BD), but partial response and non-response commonly occurs. There exists a need to identify lithium non-responders prior to initiating treatment. The Pharmacogenomics of B

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55d7bb7e93e92fc2550142370e33ba30
https://pubmed.ncbi.nlm.nih.gov/33797828

Right unilateral electroconvulsive therapy does not cause more cognitive impairment than pharmacologic treatment in treatment-resistant bipolar depression: A 6-month randomized controlled trial follow-up study

Autor: Gunnar Morken, Helle K. Schoeyen, Ute Kessler, Kjetil Sundet, Ole A. Andreassen, Bjoern H. Auestad, Ulrik Fredrik Malt, Ketil J. Oedegaard, Jeanette Bjoerke-Bertheussen, Arne E. Vaaler

Publikováno v: Bipolar Disorders. 20:531-538

Objectives Electroconvulsive therapy is an effective treatment for bipolar depression, but there are concerns about whether it causes long-term neurocognitive impairment. Methods In this multicenter randomized controlled trial, in-patients with treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61286f4d4b9bc7bc9d0f75c1344df1ea
https://doi.org/10.1111/bdi.12594

Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder

Autor: Yokesh Balaraman, Gloria Harrington, Julie Garnham, Petter Jakobsen, David K. Welsh, Szabolcs Szelinger, Martin Alda, Ney Alliey-Rodriguez, Susan G. Leckband, Ole A. Andreasson, Nicole Frazier, Abigail Ortiz, Clara Conroy, Holli Bertram, Marisa Kelly, Sarah Obral, Joseph R. Calabrese, Bruce Tarwater, Claire Slaney, Andrea Stautland, Paul D. Shilling, David Craig, Candice L. Schwebel, Cynthia V. Calkin, Scott E. Feeder, Toyomi Goto, Emma K. Stapp, Heather Wei, Elizabeth Karberg, Caroline M. Nievergelt, Melvin G. McInnis, Anna DeModena, Nicole D'Arcangelo, Kelly A. Ryan, Wade H. Berrettini, Peter P. Zandi, Keming Gao, Martha Schinagle, Michael McCarthy, Ana M. Claasen, Ketil J. Oedegaard, John I. Nurnberger, Megan Ritchey, Kristen J. Brennand, Carrie Fisher, Mark A. Frye, Fred H. Gage, John R. Kelsoe, Gunnar Morken, Fernando S. Goes, Masoud Kamali, Francis M. Mondimore, Adam X. Maihofer, Amit Anand, Tatyana Shekhtman, William Coryell, Kara Glazer, Martha Shaw, Elliot S. Gershon, Falk W. Lohoff, Srdjan Djurovic, Helle K. Schoeyen

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, vol 44, iss 3
620–628
Neuropsychopharmacology

Bipolar disorder (BD) is a serious mood disorder associated with circadian rhythm abnormalities. Risk for BD is genetically encoded and overlaps with systems that maintain circadian rhythms. Lithium is an effective mood stabilizer treatment for BD, b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ac0de8c87a672d8a9195e28864ff78
https://escholarship.org/uc/item/0p95j75v

The Pharmacogenomics of Bipolar Disorder study (PGBD): Identification of genes for lithium response in a prospective sample

Autor: Michael McCarthy, Susan G. Leckband, Keming Gao, Abesh Kumar Bhattacharjee, Ketil J. Oedegaard, Katherine E. Burdick, Anna DeModena, Jun Yao, Anit Anand, Kristen J. Brennand, Jerome Mertens, Yokesh Balaraman, Caroline M. Nievergelt, John I. Nurnberger, Petter Jakobsen, Szabolcs Szelinger, Helle K. Schoeyen, Mark A. Frye, Cynthia V. Calkin, Paul D. Shilling, Joseph R. Calabrese, Bruce Tarwater, David Craig, John R. Kelsoe, Ole A. Andreassen, Melvin G. McInnis, Son Pham, Ana M. Claasen, Martin Alda, Julie Garnham, Gunnar Morken, Adam X. Maihofer, Tatyana Shekhtman, William Coryell, Elliot S. Gershon, Fred H. Gage, Wade H. Berrettini, Peter P. Zandi

Publikováno v: BMC Psychiatry
BMC psychiatry, vol 16, iss 1

Background Bipolar disorder is a serious and common psychiatric disorder characterized by manic and depressive mood switches and a relapsing and remitting course. The cornerstone of clinical management is stabilization and prophylaxis using mood-stab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::967e06e456034cb2dfd7a2d159e0b5a0
https://hdl.handle.net/1956/17597